Literature DB >> 20060986

Triterpenoid saponins from Astragalus wiedemannianus Fischer.

Emre Polat1, Erdal Bedir, Angela Perrone, Sonia Piacente, Ozgen Alankus-Caliskan.   

Abstract

Three cycloartane-type triterpene glycosides were isolated from Astragalus wiedemannianus together with eight known secondary metabolites namely cycloastragenol, cycloascauloside B, astragaloside IV, astragaloside VIII, brachyoside B, astragaloside II, astrachrysoside A, and astrasieversianin X. The structures were established mainly by a combination of 1D and 2D-NMR techniques as 3-O-[alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranosyl]-25-O-beta-D-glucopyranosyl-20(R),24(S)-epoxy-3beta,6alpha,16beta,25-tetrahydroxycycloartane, 3-O-[alpha-L-rhamnopyranosyl-(1-->2)-beta-D-xylopyranosyl]-6-O-beta-D-glucopyranosyl-24-O-alpha-(4'-O-acetoxy)-L-arabinopyranosyl-16-O-acetoxy-3beta,6alpha,16beta,24(S),25-pentahydroxycycloartane, 3-O-[alpha-L-rhamnopyranosyl-(1-->2)-beta-D-xylopyranosyl]-6-O-beta-D-glucopyranosyl-24-O-alpha-L-arabinopyranosyl-16-O-acetoxy-3beta,6alpha,16beta,24(S),25-pentahydroxycycloartane. To the best of our knowledge, the presence of an arabinose moiety on the acyclic side chain of cycloartanes is reported for the first time. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060986     DOI: 10.1016/j.phytochem.2009.11.013

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  8 in total

1.  Beneficial Effect of Astragaloside on Alzheimer's Disease Condition Using Cultured Primary Cortical Cells Under β-amyloid Exposure.

Authors:  Ching-Ping Chang; Yu-Fan Liu; Hung-Jung Lin; Chien-Chin Hsu; Bor-Chih Cheng; Wen-Pin Liu; Mao-Tsun Lin; Shu-Fen Hsu; Li-Sheng Chang; Kao-Chang Lin
Journal:  Mol Neurobiol       Date:  2015-12-22       Impact factor: 5.590

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

3.  Comparative anti-inflammatory and hepatoprotective activities of Astragalus gummifer Labill herb and roots in rats.

Authors:  Hasan Soliman Yusufoglu; Aftab Alam; Ahmed Mohammed Zaghloul; Mohammad Ayman Al-salkini; Prawez Alam
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

4.  Exercise Rehabilitation and/or Astragaloside Attenuate Amyloid-beta Pathology by Reversing BDNF/TrkB Signaling Deficits and Mitochondrial Dysfunction.

Authors:  Yu-Lin Wang; Chung-Ching Chio; Shu-Chun Kuo; Chao-Hung Yeh; Jui-Ti Ma; Wen-Pin Liu; Mao-Tsun Lin; Kao-Chang Lin; Ching-Ping Chang
Journal:  Mol Neurobiol       Date:  2022-03-09       Impact factor: 5.590

Review 5.  The Role of Saponins in the Treatment of Neuropathic Pain.

Authors:  Bei Tan; Xueqing Wu; Jie Yu; Zhong Chen
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

6.  Total Astragalus saponins attenuates CVB3-induced viral myocarditis through inhibiting expression of tumor necrosis factor α and Fas ligand.

Authors:  Yunfeng Xiao; Tianlong Liu; Xiaoling Liu; Lanbin Zheng; Dongsheng Yu; Yuanyan Zhang; Xinyu Qian; Xiaolei Liu
Journal:  Cardiovasc Diagn Ther       Date:  2019-08

7.  Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening.

Authors:  Qinru Sun; Ning Jia; Weixi Wang; Hui Jin; Jiehua Xu; Haitao Hu
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

8.  Metabolomic approach for a rapid identification of natural products with cytotoxic activity against human colorectal cancer cells.

Authors:  Vittoria Graziani; Monica Scognamiglio; Valentina Belli; Assunta Esposito; Brigida D'Abrosca; Angela Chambery; Rosita Russo; Marta Panella; Aniello Russo; Fortunato Ciardiello; Teresa Troiani; Nicoletta Potenza; Antonio Fiorentino
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.